Treatment of a unique anemia in patients with IDDM with epoetin alfa

Diabetes Care
M U RarickD I Feinstein

Abstract

To identify and treat a unique form of anemia in patients with long-term IDDM. Patients with IDDM, unexplained symptomatic anemia, and serum creatinine levels of < 177 mumol/l (2.0 mg/dl) were treated with epoetin alfa (Procrit, Ortho Biotech, Raritan, NJ), 50 U/kg three times weekly, subcutaneously, to reach a target hematocrit of 38-40%. Baseline serum erythropoietin titers were measured before drug therapy. Six patients were treated with epoetin alfa. Median age of the group was 74 years, with IDDM being diagnosed for a median of > 20 years. All patients had symptoms of anemia with a median hematocrit of 28.9% (range 27-31). Compared with iron deficiency control patients, the group had a limited erythropoietin (EPO) response to the degree of anemia. All patients showed increases in hematocrit, median peak of 40.9%, with median time-to-peak response of 12 weeks. Baseline symptoms of anemia resolved in all patients. No adverse effects were noted during the treatment period. There is a unique form of anemia in patients with long-term IDDM and clinically normal renal function who respond to low-dose epoetin alfa therapy. The rapid response to therapy and depressed baseline erythropoietin titers suggest the anemia is due to a lac...Continue Reading

Citations

Feb 19, 2004·The American Journal of Medicine·Sang-Hoon Ahn, Harinder S Garewal
Apr 30, 2003·American Journal of Ophthalmology·Stephen H SinclairAdeera Levin
Jan 30, 2002·Clinica Chimica Acta; International Journal of Clinical Chemistry·Andrea S WinklerTimothy J Peters
Mar 1, 2002·Diabetic Medicine : a Journal of the British Diabetic Association·D R BosmanP J Watkins
Sep 19, 2003·Current Medical Research and Opinion·Paul E StevensNorbert R Lameire
Jun 3, 2008·Blood Cells, Molecules & Diseases·Elizabeth A Price
Jan 31, 2007·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Eberhard RitzUNKNOWN Anemia Correction in Diabetes Study Investigators
Jul 23, 2003·Diabetic Medicine : a Journal of the British Diabetic Association·D J KimH C Lee
Sep 29, 2004·American Journal of Nephrology·G DerayC Isnard Bagnis
Nov 5, 1999·Diabetic Medicine : a Journal of the British Diabetic Association·A S WinklerP J Watkins
Jun 27, 2000·Diabetes/metabolism Research and Reviews·P CotroneoG Ghirlanda

❮ Previous
Next ❯

Related Concepts

Related Feeds

American Diabetes Association Journals

Discover the latest diabetes research published by the journals from the American Diabetes Association.

Autoimmune Diabetes & Tolerance

Patients with type I diabetes lack insulin-producing beta cells due to the loss of immunological tolerance and autoimmune disease. Discover the latest research on targeting tolerance to prevent diabetes.

Anemia

Anemia develops when your blood lacks enough healthy red blood cells. Anemia of inflammation (AI, also called anemia of chronic disease) is a common, typically normocytic, normochromic anemia that is caused by an underlying inflammatory disease. Here is the latest research on anemia.